SCHEMBL20909892

SCHEMBL20909892

Cc1ccnc(N2CCNC2=O)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 1/20 0.47
CCR5 P51681 1/20 0.47
CCR8 P51685 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
TSHR P16473 1/20 0.44
GRIN2D O15399 1/20 0.43
GRIN3B O60391 1/20 0.43
GRIN1 Q05586 1/20 0.43
GRIN2A Q12879 1/20 0.43
GRIN2B Q13224 1/20 0.43
GRIN2C Q14957 1/20 0.43
GRIN3A Q8TCU5 1/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
POLB P06746 1/20 0.42
ALDH1A1 P00352 3/20 0.41
LMNA P02545 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3782058 0.81 CCR1 (0.52) CCR1CCR5CCR8CYP3A4CYP2C9
SCHEMBL12594227 0.80 NOS3 (0.45) CYP3A4CYP2C9CYP2C19TSHRMEN1
SCHEMBL20890601 0.80 MAP3K5 (0.41) CYP3A4TSHRKMT2ASMN1; SMN2MAP3K5
SCHEMBL19454936 0.77 TDO2 (0.48) CYP3A4TSHRGRIN2DGRIN3BGRIN1
SCHEMBL1569134 0.76 PIK3CA (0.55)
SCHEMBL21858471 0.76 ADRB1 (0.60) ALDH1A1EGLN2KDM4ENOS3NOS2
SCHEMBL10275026 0.75 CCR1 (0.50) CCR1CCR5CCR8CYP3A4CYP2C9
SCHEMBL17263330 0.75 PIK3CA (0.61) MEN1KMT2AALDH1A1KDM4ENPC1
SCHEMBL1568266 0.75 KDM4C (0.50) TSHRPOLBSMN1; SMN2KDM4ENPC1
SCHEMBL12859179 0.74 CYP3A4 (0.48) CCR1CCR5CCR8CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102803250-A 1, 3-disubstituted imidazolidin-2-one derivatives as inhibitors of CYP17 NOVARTIS AG 2012-11-28 CN claimed
WO-2019074979-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF GIRAFPHARMA, LLC (US) 2019-04-18 WO disclosed
CN-102803250-B 1, 3-disubstituted imidazolidin-2-one derivatives as inhibitors of CYP17 NOVARTIS AG 2014-04-16 CN disclosed
CN-102803250-A 1, 3-disubstituted imidazolidin-2-one derivatives as inhibitors of CYP17 NOVARTIS AG 2012-11-28 CN disclosed